BURLINGTON, Mass., July 31, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today reported Q2 2012 sales of $14.4mm and operating profit of $1.5mm. The Company also approved a quarterly cash dividend of $0.025 per share, and provided Q3 2012 and full-year 2012 guidance.
